These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 6372876

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin.
    Prabakaran S, Tepp W, DasGupta BR.
    Toxicon; 2001 Oct; 39(10):1515-31. PubMed ID: 11478959
    [Abstract] [Full Text] [Related]

  • 24. Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813.
    Terajima J, Syuto B, Ochanda JO, Kubo S.
    Infect Immun; 1985 May; 48(2):312-7. PubMed ID: 3988338
    [Abstract] [Full Text] [Related]

  • 25. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
    Ochanda JO, Syuto B, Oguma K, Iida H, Kubo S.
    Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
    [Abstract] [Full Text] [Related]

  • 26. Covalent structure of botulinum neurotoxin type E: location of sulfhydryl groups, and disulfide bridges and identification of C-termini of light and heavy chains.
    Antharavally BS, DasGupta BR.
    J Protein Chem; 1997 Nov; 16(8):787-99. PubMed ID: 9365927
    [Abstract] [Full Text] [Related]

  • 27. Changes in the molecular topography of the light and heavy chains of type A botulinum neurotoxin following their separation.
    Singh BR, DasGupta BR.
    Biophys Chem; 1989 Nov; 34(3):259-67. PubMed ID: 2611349
    [Abstract] [Full Text] [Related]

  • 28. Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.
    Kozaki S, Ogasawara J, Shimote Y, Kamata Y, Sakaguchi G.
    Infect Immun; 1987 Dec; 55(12):3051-6. PubMed ID: 2824382
    [Abstract] [Full Text] [Related]

  • 29. Cloning, expression, and purification of C-terminal quarter of the heavy chain of botulinum neurotoxin type A.
    Sharma S, Zhou Y, Singh BR.
    Protein Expr Purif; 2006 Feb; 45(2):288-95. PubMed ID: 16143544
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Purification and amino acid composition of type E botulinum neurotoxin.
    DasGupta BR, Rasmussen S.
    Toxicon; 1983 Feb; 21(4):535-45. PubMed ID: 6353669
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution.
    Syuto B, Kubo S.
    J Biol Chem; 1981 Apr 25; 256(8):3712-7. PubMed ID: 6783645
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.